Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
5
VanEck Oil Services ETF
OIH
No Data
RBC Capital Maintains Outperform on Biogen, Raises Price Target to $227
RBC Capital Maintains Biogen(BIIB.US) With Buy Rating, Raises Target Price to $227
RBC Lifts Price Target on Biogen to $227 From $222, Keeps Outperform Rating
Biogen Faces Italian Antitrust Probe Over Multiple Sclerosis Drug Competition
Citi Remains a Hold on Merck & Company (MRK)
Wells Fargo Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $250